Literature DB >> 26233836

Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease.

Zobair M Younossi1,2, Linda Henry3,4,5.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a very common chronic liver disease worldwide, is on the rise following the trend of increasing prevalence of obesity, is the second most common indication for liver transplantation, and is an important cause for hepatocellular carcinoma. Despite the increasing recognition of NAFLD as an important chronic liver disease, little has been published on the economic and health-related quality of life (HR-QOL) impact of NAFLD. We reviewed the current literature related to the economics and HR-QOL of NAFLD and found that increased costs and decreased HR-QOL were associated with NAFLD.

Entities:  

Mesh:

Year:  2015        PMID: 26233836     DOI: 10.1007/s40273-015-0316-5

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  44 in total

Review 1.  Nonalcoholic fatty liver disease and aging: epidemiology to management.

Authors:  Marco Bertolotti; Amedeo Lonardo; Chiara Mussi; Enrica Baldelli; Elisa Pellegrini; Stefano Ballestri; Dante Romagnoli; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 2.  From the metabolic syndrome to NAFLD or vice versa?

Authors:  Ester Vanni; Elisabetta Bugianesi; Anna Kotronen; Samuele De Minicis; Hannele Yki-Järvinen; Gianluca Svegliati-Baroni
Journal:  Dig Liver Dis       Date:  2010-03-06       Impact factor: 4.088

3.  Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery.

Authors:  Kevin B Barker; Nicole A Palekar; Steven P Bowers; Joel E Goldberg; Joseph P Pulcini; Stephen A Harrison
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

4.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

Authors:  Robert J Wong; Maria Aguilar; Ramsey Cheung; Ryan B Perumpail; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2014-11-25       Impact factor: 22.682

5.  Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease.

Authors:  Julia L Newton; Jessie Pairman; Katharine Wilton; David E J Jones; Christopher Day
Journal:  Clin Auton Res       Date:  2009-12       Impact factor: 4.435

6.  Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life.

Authors:  I J Hickman; J R Jonsson; J B Prins; S Ash; D M Purdie; A D Clouston; E E Powell
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

7.  Prevalence and associated metabolic factors of fatty liver disease in the elderly.

Authors:  Zhongli Wang; Ming Xu; Jianhong Peng; Li Jiang; Zhengguo Hu; Hua Wang; Shiqing Zhou; Rui Zhou; Michael Hultström; En Yin Lai
Journal:  Exp Gerontol       Date:  2013-05-27       Impact factor: 4.032

Review 8.  Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.

Authors:  N J Barshop; C B Sirlin; J B Schwimmer; J E Lavine
Journal:  Aliment Pharmacol Ther       Date:  2008-04-04       Impact factor: 8.171

9.  Depression and anxiety in nonalcoholic steatohepatitis: is there any association?

Authors:  Teodora Surdea-Blaga; Dan L Dumitraşcu
Journal:  Rom J Intern Med       Date:  2011

Review 10.  The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Authors:  J Picot; J Jones; J L Colquitt; E Gospodarevskaya; E Loveman; L Baxter; A J Clegg
Journal:  Health Technol Assess       Date:  2009-09       Impact factor: 4.014

View more
  27 in total

1.  Is possible to detect nonalcoholic fatty liver disease by a new index including single nucleotide polymorphisms (SNPs)?

Authors:  Ludovico Abenavoli; Luigi Boccuto
Journal:  Ann Transl Med       Date:  2018-09

Review 2.  Defining comprehensive models of care for NAFLD.

Authors:  Manuel Romero-Gómez; Jörn M Schattenberg; Jeffrey V Lazarus; Quentin M Anstee; Hannes Hagström; Kenneth Cusi; Helena Cortez-Pinto; Henry E Mark; Michael Roden; Emmanuel A Tsochatzis; Vincent Wai-Sun Wong; Zobair M Younossi; Shira Zelber-Sagi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-25       Impact factor: 46.802

Review 3.  The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View.

Authors:  Christina C Lindenmeyer; Arthur J McCullough
Journal:  Clin Liver Dis       Date:  2018-02       Impact factor: 6.126

Review 4.  Metabolic aspects of adult patients with nonalcoholic fatty liver disease.

Authors:  Ludovico Abenavoli; Natasa Milic; Laura Di Renzo; Tomislav Preveden; Milica Medić-Stojanoska; Antonino De Lorenzo
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

5.  Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study.

Authors:  Mark G Swain; Alnoor Ramji; Keyur Patel; Giada Sebastiani; Abdel Aziz Shaheen; Edward Tam; Paul Marotta; Magdy Elkhashab; Harpreet S Bajaj; Chris Estes; Homie Razavi
Journal:  CMAJ Open       Date:  2020-06-09

6.  Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States.

Authors:  Ilya Golovaty; Phyllis C Tien; Jennifer C Price; Lila Sheira; Hilary Seligman; Sheri D Weiser
Journal:  J Nutr       Date:  2020-01-01       Impact factor: 4.798

Review 7.  Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Valerio Nobili; Anna Alisi; Kimberly P Newton; Jeffrey B Schwimmer
Journal:  Gastroenterology       Date:  2016-03-19       Impact factor: 22.682

Review 8.  Natural History of Nonalcoholic Fatty Liver Disease.

Authors:  George Boon-Bee Goh; Arthur J McCullough
Journal:  Dig Dis Sci       Date:  2016-03-22       Impact factor: 3.199

9.  Burden and Predictors of Non-Alcoholic Fatty Liver Disease in a Retrospective Cohort of Patients With Crohn's Disease.

Authors:  Ahmed Abomhya; Mohammed Mahmoodurrahman; Salman Ayaz; Hossam Hamad; Farrah Khan
Journal:  Gastroenterology Res       Date:  2022-04-12

Review 10.  Nonalcoholic Fatty Liver Disease.

Authors:  Lingling Ding; Yvonne Oligschlaeger; Ronit Shiri-Sverdlov; Tom Houben
Journal:  Handb Exp Pharmacol       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.